InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,424.00
(
0.11%
)
Dow Jones
38,778.10
(
0.00%
)
Brent Oil
83.76
(
-0.17%
)
Bitcoin
65,344.11
(
-1.72%
)
Post# of 252235
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: bladerunner1717 post# 145901

Monday, 07/23/2012 6:08:42 PM

Monday, July 23, 2012 6:08:42 PM

Post# of 252235
Yes. ARQL already finished ph1 for Nexavar in combination with Tivantinib. No surprise, there are activities there. Now they need to choose indications to do randomized ph2. I am not aware which ones they choose yet.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up